The document outlines a clinical disease activity index (CDAI) used to measure the severity of Crohn's disease in 4 categories: asymptomatic remission at 0-149 points, mildly to moderately active at 150-220 points, moderately to severely active at 221-450 points, and severely active to fulminant at 451-1100 points. Higher CDAI scores indicate more severe Crohn's disease symptoms.
The document outlines a clinical disease activity index (CDAI) used to measure the severity of Crohn's disease in 4 categories: asymptomatic remission at 0-149 points, mildly to moderately active at 150-220 points, moderately to severely active at 221-450 points, and severely active to fulminant at 451-1100 points. Higher CDAI scores indicate more severe Crohn's disease symptoms.
The document outlines a clinical disease activity index (CDAI) used to measure the severity of Crohn's disease in 4 categories: asymptomatic remission at 0-149 points, mildly to moderately active at 150-220 points, moderately to severely active at 221-450 points, and severely active to fulminant at 451-1100 points. Higher CDAI scores indicate more severe Crohn's disease symptoms.
The document outlines a clinical disease activity index (CDAI) used to measure the severity of Crohn's disease in 4 categories: asymptomatic remission at 0-149 points, mildly to moderately active at 150-220 points, moderately to severely active at 221-450 points, and severely active to fulminant at 451-1100 points. Higher CDAI scores indicate more severe Crohn's disease symptoms.